Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Portfolio Pulse from Avi Kapoor
Analysts have spotlighted three high-dividend yielding healthcare stocks: Organon & Co. (OGN), Premier, Inc. (PINC), and GSK plc (GSK). Organon has mixed analyst ratings with a recent downgrade, Premier has been downgraded and had its price target cut, while GSK received a buy rating and an FDA application acceptance for a new drug.
October 21, 2024 | 1:12 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Premier, Inc. offers a 4.15% dividend yield. Analysts have downgraded the stock and cut its price target. Financial results for Q1 fiscal 2025 are expected on Nov. 5, which may influence stock movement.
The downgrades and price target cut suggest a negative outlook. The upcoming financial results could either confirm or counter this sentiment, but the current analyst stance is likely to pressure the stock.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 75
NEUTRAL IMPACT
Organon & Co. has a high dividend yield of 6.36%. Analysts have mixed views: JP Morgan downgraded it to Underweight, while Piper Sandler maintained an Overweight rating. Upcoming Q3 results on Oct. 31 could impact stock performance.
The mixed analyst ratings suggest uncertainty in the stock's short-term performance. The upcoming financial results could provide more clarity, but the downgrade may weigh on investor sentiment.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
GSK plc has a 3.97% dividend yield. Analysts have a positive outlook with a recent upgrade and FDA acceptance of a new drug application, which could boost investor confidence.
The positive analyst ratings and FDA acceptance of a new drug application are likely to boost investor confidence and support the stock's short-term performance.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 85